| 1. | Src family of protein tyrosine kinases
蛋白质酪氨酸激酶的 |
| 2. | Tec btk family tyrosine kinasestec btk
家族的酪氨酸激酶 |
| 3. | Syk family of protein tyrosine kinases
蛋白质酪氨酸激酶 |
| 4. | Is pdgf tyrosine kinase inhibitor effective in pancreatic cancer
Pdgf受体酪氨酸激酶抑制剂在胰腺癌中是否有作用 |
| 5. | Effect of cholesterol defeciency on the activity of protein tyrosine kinases in jurkat cells
细胞蛋白酪氨酸激酶活性的影响 |
| 6. | Three - dimensional quantitative structure - activity relationship study of tyrosine kinase inhibitors
酪氨酸激酶抑制剂的三维定量构效关系研究 |
| 7. | The progress in tyrosine kinase inhibitor has been reviewed , including the chemical structures and the pharmacophore models
本文综述了近年来酪氨酸激酶抑制剂的研究进展，包括抑制剂的结构和与激酶作用的药效团模型。 |
| 8. | Tyrosine kinases are attractive as targets in the research of therapeutic agents , not only against cancer , hut also against many other diseases
在包括癌症和其他许多疾病的治疗研究中，酪氨酸激酶都是研究的目标和对象。 |
| 9. | Il - 2 decreased l / dtmax , dl and end - diastolic cell length . inactive il - 2 at 50 u / ml did not significantly decrease l / dtmax , dl , or cell length
2对心肌细胞收缩的抑制作用；酪氨酸激酶抑制剂genistcin （ 100卜r口offe ）预处理后，对il 2的心肌细胞收缩抑制作用无明显影响。 |
| 10. | Gefitinib ( iressa , zd1839 ) , a specific tyrosine kinase inhibitor that targets the epidermal growth factor receptor ( egfr ) , is a novel molecular - targeting antineoplastic agent
摘要吉非替尼是一种新型的分子靶向抗癌药物，它选择性抑制表皮生长因子受体酪氨酸激酶而发挥作用。 |
